Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBAVIRIN vs RIFAXIMIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBAVIRIN vs RIFAXIMIN: Safety Overview

Metric RIBAVIRIN RIFAXIMIN
Total FAERS Reports 43,397 13,861
Deaths Reported 2,494 5,009
Death Rate 5.7% 36.1%
Hospitalizations 8,495 4,847
Average Patient Age 55.7 yrs 63.2 yrs
% Female Patients 44.3% 54.9%
FDA Approval Date Apr 18, 2008 Mar 24, 2010
Manufacturer Aurobindo Pharma Limited Salix Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription